Literature DB >> 8683393

Diagnostic value of different PCR assays for the detection of mycobacterial DNA in granulomatous lymphadenopathy.

M Tötsch1, W Böcker, E Brömmelkamp, M Fille, A Kreczy, D Ofner, K W Schmid, B Dockhorn-Dworniczak.   

Abstract

Diagnosis of mycobacterial infection is made by assessment of characteristic histological features, staining of acid-fast bacilli, or agar culture. Recent advances in molecular biology have provided alternative approaches for the detection of mycobacteria, but only limited data are available dealing with the comparative evaluation of these methods. In order to determine the diagnostic applicability of polymerase chain reaction (PCR)-based assays, 20 formalin-fixed and paraffin-embedded lymph nodes with bacille Calmette-Guérin (BCG) lymphadenitis were investigated which in Löwenstein Jensen agar culture were either positive or negative (ten cases each); ten lymph nodes with non-specific lymphadenitis served as negative controls. Ziehl-Neelsen staining as well as three different PCR assays (including nested PCR), amplifying a specific sequence of the Mycobacterium tuberculosis complex or sequences of the 65 kD antigen gene, were performed. Positive culture was only obtained from lymph nodes which had been surgically removed within 20 weeks after vaccination (P < 0.001). In contrast to microscopic examination, which yielded no more information than agar culture, PCR detection of mycobacterial DNA was unrelated to culture findings. Combined use of different assays, as well as DNA extraction from at least three paraffin sections from each specimen, resulted in the detection of mycobacterial DNA in all lymph nodes with amplifiable DNA (18 out of 20 cases). Controls remained consistently negative. Thus, the combined use of different PCR assays is proposed as a rapid and sensitive technique for the detection of mycobacterial DNA in formalin-fixed and paraffin-embedded tissue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683393     DOI: 10.1002/(SICI)1096-9896(199602)178:2<221::AID-PATH441>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  PCR based detection of mycobacteria in paraffin wax embedded material routinely processed for morphological examination.

Authors:  T Frevel; K L Schäfer; M Tötsch; W Böcker; B Dockhorn-Dworniczak
Journal:  Mol Pathol       Date:  1999-10

2.  Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection.

Authors:  Sandra Lassalle; Eric Selva; Véronique Hofman; Catherine Butori; Nicolas Vénissac; Jérôme Mouroux; Pierre Dellamonica; Paul Hofman
Journal:  Virchows Arch       Date:  2006-10-17       Impact factor: 4.064

3.  Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy.

Authors:  K K Singh; M Muralidhar; A Kumar; T K Chattopadhyaya; K Kapila; M K Singh; S K Sharma; N K Jain; J S Tyagi
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

4.  Identification of mycobacteria to the species level by automated restriction enzyme fragment length polymorphism analysis.

Authors:  M Tötsch; E Brömmelkamp; A Stücker; M Fille; R Gross; P Wiesner; K W Schmid; W Böcker; B Dockhorn-Dworniczak
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children.

Authors:  E S Bruijnesteijn Van Coppenraet; J A Lindeboom; J M Prins; M F Peeters; E C J Claas; E J Kuijper
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  4 years' experience of head and neck tuberculosis in a south London hospital.

Authors:  N Choudhury; G Bruch; P Kothari; G Rao; R Simo
Journal:  J R Soc Med       Date:  2005-06       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.